학술논문

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data
Document Type
Article
Source
In: Clinical Genitourinary Cancer. (Clinical Genitourinary Cancer, June 2024, 22(3))
Subject
Language
English
ISSN
19380682
15587673